Display Settings:


Send to:

Choose Destination
See comment in PubMed Commons below
J Med Chem. 2008 Dec 11;51(23):7635-9. doi: 10.1021/jm800854e.

Triazine compounds as antagonists at Bv8-prokineticin receptors.

Author information

  • 1Department of Pharmaceutical Sciences, University of Ferrara, I-44100 Ferrara, Italy. gbalboni@unica.it


On the basis of a Janssen's patent, we approached a new synthesis of some 1,3,5-triazin-4,6-diones as potential non peptidic prokineticin receptor antagonists, containing the following substitutions: (N(1) and N(5) link a 4-methoxybenzyl and a 4-ethylbenzyl, respectively; C(2) can link an amino-ethyl-guanidine (reference compound 1) or an ethylendiamine (2) or an amino-ethyl-amino-2-imidazoline (3). New compounds were assessed for PKR1 and PKR2 affinity. Antagonist properties were evaluated as inhibition of 1 nM Bv8-induced intracellular Ca2+ mobilization.

[PubMed - indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for American Chemical Society
    Loading ...
    Write to the Help Desk